Gelomics raised $2.2 million in a pre-Seed round led by Jelix Ventures to develop animal-free medical research technology
Amount Raised
$2.2 Million
Round Type
Pre-Seed
BrisbaneBiotechnologyInvestors
Description
Brisbane biotech startup Gelomics has raised $2.2 million in pre-Seed funding to support the development of its 3D tissue culture system, which aims to eliminate the need for animal testing in pharmaceutical drug development. The round was led by Jelix Ventures and included the Queensland Investment Corporation (QIC) Enterprise Acceleration Fund and Angelloop.
Quick answer
Gelomics raised $2.2 Million in a Pre-Seed round, dated July 5, 2024. Investors: Jelix Ventures, Queensland Investment Corporation (Qic) Enterprise Acceleration Fund and Angelloop. Gelomics is based in Brisbane, Queensland, Australia.
- How much did Gelomics raise?
- Gelomics raised $2.2 Million in a Pre-Seed round on July 5, 2024.
- Who invested in Gelomics?
- Jelix Ventures, Queensland Investment Corporation (Qic) Enterprise Acceleration Fund and Angelloop are named as investors in this round.
- What does Gelomics do?
- Gelomics is a Brisbane biotech startup that has developed a 3D tissue culture system, aiming to eliminate the need for animal testing in pharmaceutical drug development.
- Where is Gelomics based and how big is it?
- Gelomics is based in Brisbane, Queensland, Australia. Fundz records about 13 employees.
- Who are the decision-makers at Gelomics?
- Fundz holds 1 contact at Gelomics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Gelomics that raised within 45 days of this round, from Fundz verified event records.
- Modifi Bio raised $996K (Seed) on August 19, 2024.
- Candid Therapeutics raised $206M on August 19, 2024.
- Spotless Materials raised $1.6M (Seed) on August 19, 2024.
- Metakosmos raised $2M (Pre-Seed) on August 19, 2024.
- Viome raised $25M on August 19, 2024.
- MolecuLight raised $12M (Series C) on August 16, 2024.
Who to call at Gelomics, and when
A new round usually means Gelomics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Gelomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gelomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gelomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gelomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Gelomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.